A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
about
Mycophenolate mofetil for relapsing-remitting multiple sclerosisMycophenolate mofetil for relapsing-remitting multiple sclerosisRole of immunosuppressive therapy for the treatment of multiple sclerosisCurrent and emerging therapies in multiple sclerosis: a systematic reviewProspective randomized trial of venous angioplasty in MS (PREMiSe)Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study.Astrocytes in the tempest of multiple sclerosis.Immunotherapy of multiple sclerosis: the state of the art.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis.Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
P2860
Q24197935-D6BB80C3-A3D3-44A4-B611-6A43A66CFD43Q24200517-5A4ED681-0A33-497F-BA16-499EDE58A10EQ26827467-00133E22-1780-4FDD-AA49-C5233A30EBCFQ29010983-0456A7E6-5469-428A-B0C4-7B5EA32C3964Q33164464-B54CEDBA-8FFA-4944-801A-925A9B5EA455Q34713974-E8417706-5EA5-472D-9C40-87B0A1BD70A7Q37858667-F752C991-1203-409E-BAA8-4FED6BFCE904Q38083041-B88CB30E-4832-4BF0-B518-07B710A6BAE1Q38087925-0E7563FA-C146-4859-8602-0F83C9B13350Q38801807-98581033-14D3-455A-813D-F2D1D8CC38A5Q39032639-0691B580-630B-4A50-8F21-465004E3A16BQ45113442-ED31E2F1-EA41-4A02-A72A-DEF6DD312D66Q46816215-9FFD076F-4B70-4DFC-9334-5B0AE941D8FFQ48143686-D637A1C1-BEB9-45AC-A956-21C43E54BDAC
P2860
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@ast
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@en
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@nl
type
label
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@ast
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@en
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@nl
prefLabel
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@ast
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@en
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@nl
P2093
P2860
P50
P921
P356
P1476
A randomized, blinded, paralle ...... -remitting multiple sclerosis.
@en
P2093
Amber Salter
Amy Conger
Angela Bates
Anjali Shah
Ellen Carl
Elliot M Frohman
Eric Lindzen
Gary Cutter
Gina Remington
Hongjiang Gao
P2860
P356
10.1177/1756285609353354
P577
2010-01-01T00:00:00Z